William Blair Starts Ventrus Biosciences (VTUS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts VTUS Hot Sheet
Price: $1.45 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Join SI Premium – FREE
William Blair initiates coverage on Ventrus Biosciences (NASDAQ: VTUS) with an Outperform. PT $30.00.
For an analyst ratings summary and ratings history on Ventrus Biosciences click here. For more ratings news on Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $10.04 yesterday.
For an analyst ratings summary and ratings history on Ventrus Biosciences click here. For more ratings news on Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $10.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Glencore Plc (GLC:AU) (GLCNF) at Buy
- Goldman Sachs Starts Endeavour Mining (EDV:LN) at Buy
- Goldman Sachs Starts AngloGold Ashanti Ltd. (ANG:SJ) (AU) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
